Dopamine excretion in benign pheochromocytoma.

PubWeight™: 0.81‹?›

🔗 View Article (PMID 747729)

Published in Biomedicine on November 01, 1978

Authors

P A Serrano, B Chavez-Lara, G Sanchez-Torres

Articles citing this

Raised dopamine metabolites in a case of malignant paraganglioma. Postgrad Med J (1990) 0.82

Articles by these authors

Short-term, intermediate-term, and long-term memories. Behav Brain Res (1993) 0.99

Effect of propranolol on catecholamine content of injured cardiac tissue. J Mol Cell Cardiol (1971) 0.82

[Determination of the tumor marker CA 72-4 in gastric carcinoma]. Rev Esp Enferm Dig (1993) 0.77

Immunologic studies in patients with Takayasu's arteritis. III. Immunoregulatory changes. Clin Exp Rheumatol (1990) 0.77

[Hypotension, mental disorders and changes in catecholamine excretion observed during the administration of disulfiram in a case of pheochromocytoma]. Arch Inst Cardiol Mex (1978) 0.76

[The renin angiotensin system in the pathology of arterial hypertension of aortic coarctation]. Arch Inst Cardiol Mex (1978) 0.76

[Intestinal obstruction caused by solitary colonic metastasis of breast carcinoma]. Rev Esp Enferm Dig (1998) 0.75

[3H dopamine disappearance rate in normotensive and hypertensive patients]. Arch Inst Cardiol Mex (1982) 0.75

[Effect of sub-pressor doses of dopamine on renin secretion in the anesthetized dog]. Arch Inst Cardiol Mex (1981) 0.75

[Recent progress in the knowledge of arterial hypertension. V. Arterial hypertension of endocrine origin]. Gac Med Mex (1967) 0.75

[Effect of anoxia on the concentration of tissue serotonin in female rats]. Arch Inst Cardiol Mex (1966) 0.75

[Administration of a dopamine-hydroxylase inhibitor to Parkinson's disease patients]. Prensa Med Mex (1971) 0.75

[Not Available]. Bol Soc Mex Hist Filos Med (1985) 0.75

[Dopamine in essential arterial hypertension: excretion of its metabolite homovanillic acid]. Arch Inst Cardiol Mex (1975) 0.75

[Urinary excretion of adrenaline, noradrenaline and dopamine in essential arterial hypertension]. Rev Clin Esp (1979) 0.75

[Metabolic changes in survivors of myocardial infarct]. Arch Inst Cardiol Mex (1973) 0.75

Evaluation of a screening test for hyperlipidemia. JAMA (1974) 0.75

[Don Gregorio Marañón as seen by a Mexican doctor]. Prensa Med Mex (1971) 0.75

[L-dopa in sexual impotence in the diabetic]. Prensa Med Mex (1972) 0.75

[The use of alpha-1-24 ACTH for rapid adrenal stimulation (author's transl)]. Rev Invest Clin (1975) 0.75

[Do extra-adrenal pheochromocytomas excrete adrenaline? Study on fluorimetric interference in the differential measurement of catecholamines]. Arch Inst Cardiol Mex (1974) 0.75

[Dopamine: excretion in normal, hypertensive and thyroid subjects]. Arch Inst Cardiol Mex (1968) 0.75

[Stability of tissular catecholamines in samples obtained in different postmortem periods from rats]. Rev Invest Clin (1972) 0.75

[Diabetes and hyperlipoproteinemia in coronary atherosclerosis]. Acta Diabetol Lat (1972) 0.75

[Possible participation of catecholamines in the etiopathogenesis of essential arterial hypertension]. Arch Inst Cardiol Mex (1978) 0.75

Association between Takayasu's arteritis and cutaneous polyarteritis nodosa. Am J Med (1987) 0.75

[Atherosclerosis]. Arch Inst Cardiol Mex (1972) 0.75

[Plasma catecholamines; values in normal subjects and its use the localization of pheochromocytoma]. Arch Inst Cardiol Mex (1977) 0.75

[10 years of progress on studies done on monoamines]. Gac Med Mex (1969) 0.75

[Endocrine factors in bronchial asthma]. Alergia (1972) 0.75

[Determination of urinary catecholamines during the pharmacological tests for the diagnosis of pheochromocytoma]. Arch Inst Cardiol Mex (1969) 0.75

[Unfamiliar and early ulceromutilating acropathy combined with discal amyotrophies and malformations]. Rev Clin Esp (1969) 0.75

[Endocrinal and humoral factors in the physiopathology and therapy of bronchial asthma]. Rev Invest Clin (1973) 0.75

[Stimulation of the central dopaminergic receptor in essential hypertensive patients using amantadine]. Arch Inst Cardiol Mex (1987) 0.75

[Brain serotonin and thyroidectomy]. Rev Invest Clin (1967) 0.75

[Carcinoma of the esophagus: risk factors of morbimortality following esophagectomy]. Rev Esp Enferm Dig (1994) 0.75

[Renin-angiotensin-aldosterone system in the treatment of essential hypertension with a beta-adrenergic blocker: sotalol]. Arch Inst Cardiol Mex (1977) 0.75

[Pyogenic liver abscess as a complication of Crohn's disease]. An Med Interna (2000) 0.75

[The adrenal medulla]. Gac Med Mex (1978) 0.75

[Tendometry in the study of the thyroid function. Clinical evaluation]. Prensa Med Mex (1971) 0.75

[Effect of oxandrolone on the serum lipids in type IV and IIb hyperlipidemia]. Arch Inst Cardiol Mex (1973) 0.75

[Effect of inhibition of converting enzyme by captopril on arterial pressure, renin and aldosterone in essential hypertension]. Arch Inst Cardiol Mex (1982) 0.75

[Dopamine: the 3d endogenous amine. Observations on dopamine excretion in patients with cardiovascular pathology]. Gac Med Mex (1972) 0.75

Changes of tissue serotonin and catecholamine concentrations after asphyxia and anoxia. Dis Chest (1966) 0.75

[Concepts on the management of diabetic patients]. Arch Inst Cardiol Mex (1972) 0.75

[Coronary risk factors. Review of their main parameters (and report of data of our department]. Arch Inst Cardiol Mex (1974) 0.75

[Circadian rhythms. Trials of etiopathogenecity and correlation]. Gac Med Mex (1976) 0.75

[Inhibition of thyroid uptake of radioactive iodine by a cardiac glycoside]. Arch Inst Cardiol Mex (1973) 0.75

[Cyrcadian rhythms: chronobiology. I. Introduction]. Gac Med Mex (1976) 0.75

[Effect of levodopa on the arterial pressure and the metabolism of catecholamines in essential hypertension]. Arch Inst Cardiol Mex (1978) 0.75

[Pheochromocytoma and catecholamines. Experience in 63 cases studied for 25 years]. Arch Inst Cardiol Mex (1984) 0.75

Energy metabolism and hormonal profile in children with edematous protein-calorie malnutrition. J Pediatr (1975) 0.75

[Biosynthesis and metabolism of catecholamines: cardiovascular considerations]. Arch Inst Cardiol Mex (1969) 0.75

[Arterial damage and the renin-angiotensin system in essential hypertension. Study of 63 cases]. Arch Inst Cardiol Mex (1978) 0.75

[Urinary elimination of catecholamines in surgeons and in patients during open heart surgery]. Arch Inst Cardiol Mex (1969) 0.75

False-positive dopamine in pheochromocytoma treated with tyrosine derivative. JAMA (1973) 0.75

[Disulfiram and L-dopa in patients with Parkinson's syndrome and in torsion dystonia]. Prensa Med Mex (1973) 0.75

[Primary aldosteronism. Diagnostic aspects and treatment]. Arch Inst Cardiol Mex (1981) 0.75

[Trial of L-dopa as hypotensive medication in arterial hypertension. Preliminary report]. Arch Inst Cardiol Mex (1974) 0.75